Skip to content

Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide

C12H29N4O4P — CID 141315652

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACdiazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide
SMILESCC(=O)N[C@@H](C(C)C)[C@H]1CC=C(P(=O)([O-])[O-])C[C@@H]1N.[NH4+].[NH4+]
InChIInChI=1S/C12H23N2O4P.2H3N/c1-7(2)12(14-8(3)15)10-5-4-9(6-11(10)13)19(16,17)18;;/h4,7,10-12H,5-6,13H2,1-3H3,(H,14,15)(H2,16,17,18);2*1H3/t10-,11-,12-;;/m0../s1
InChIKeyLXRHHAYTKSDAQG-MGKSKXMVSA-N
MW324.36 g/mol
LogP0.43
Rot. Bonds4

About Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide

Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide (PubChem CID 141315652) has the molecular formula C12H29N4O4P and a molecular weight of 324.36 g/mol. Its IUPAC name is diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide.

Molecular Properties

Compound NameDiazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide
PubChem CID141315652
Molecular FormulaC12H29N4O4P
Molecular Weight324.36 g/mol
Exact Mass324.19
IUPAC Namediazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide
SMILESCC(=O)N[C@@H](C(C)C)[C@H]1CC=C(P(=O)([O-])[O-])C[C@@H]1N.[NH4+].[NH4+]
InChIInChI=1S/C12H23N2O4P.2H3N/c1-7(2)12(14-8(3)15)10-5-4-9(6-11(10)13)19(16,17)18;;/h4,7,10-12H,5-6,13H2,1-3H3,(H,14,15)(H2,16,17,18);2*1H3/t10-,11-,12-;;/m0../s1
InChIKeyLXRHHAYTKSDAQG-MGKSKXMVSA-N
XLogP0.43
TPSA191.31 Ų
H-Bond Donors4
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500324.36
LogP ≤ 50.43
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide?
The IUPAC name of Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide (CID 141315652) is diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide.
What is the SMILES notation for Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide?
The canonical SMILES for Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide is CC(=O)N[C@@H](C(C)C)[C@H]1CC=C(P(=O)([O-])[O-])C[C@@H]1N.[NH4+].[NH4+].
What is the InChIKey of Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide?
The InChIKey is LXRHHAYTKSDAQG-MGKSKXMVSA-N. The full InChI is InChI=1S/C12H23N2O4P.2H3N/c1-7(2)12(14-8(3)15)10-5-4-9(6-11(10)13)19(16,17)18;;/h4,7,10-12H,5-6,13H2,1-3H3,(H,14,15)(H2,16,17,18);2*1H3/t10-,11-,12-;;/m0../s1.
What are the key properties of Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide?
Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide has a molecular weight of 324.36 g/mol, XLogP of 0.43, 4 rotatable bonds, 4 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for Diazanium;N-[(1S)-1-[(1S,6S)-6-amino-4-phosphonatocyclohex-3-en-1-yl]-2-methylpropyl]acetamide is sourced from PubChem (CID 141315652), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.